%0 Journal Article
%T "GOLD or lower limit of normal definition? a comparison with expert-based diagnosis of chronic obstructive pulmonary disease in a prospective cohort-study"
%A G¨¹lmisal G¨¹der
%A Susanne Brenner
%A Christiane E Angermann
%A Georg Ertl
%A Matthias Held
%A Alfred P Sachs
%A Jan-Willem Lammers
%A Pieter Zanen
%A Arno W Hoes
%A Stefan St£¿rk
%A Frans H Rutten
%J Respiratory Research
%D 2012
%I BioMed Central
%R 10.1186/1465-9921-13-13
%X In a prospective cohort study, 405 patients aged ¡İ 65 years with a general practitioner's diagnosis of COPD were recruited and followed up for 4.5 (median; quartiles 3.9; 5.1) years. Prevalence rates of COPD according to GOLD and three LLN definitions and diagnostic performance measurements were calculated. The reference standard was the diagnosis of COPD of an expert panel that used all available diagnostic information, including spirometry and bodyplethysmography.Compared to the expert panel diagnosis, 'GOLD-COPD' misclassified 69 (28%) patients, and the three LLNs misclassified 114 (46%), 96 (39%), and 98 (40%) patients, respectively. The GOLD classification led to more false positives, the LLNs to more false negative diagnoses. The main predictors beyond the FEV1/FVC ratio for an expert diagnosis of COPD were the FEV1 % predicted, and the residual volume/total lung capacity ratio (RV/TLC). Adding FEV1 and RV/TLC to GOLD or LLN improved the diagnostic accuracy, resulting in a significant reduction of up to 50% of the number of misdiagnoses. The expert diagnosis of COPD better predicts exacerbations, hospitalizations and mortality than GOLD or LLN.GOLD criteria over-diagnose COPD, while LLN definitions under-diagnose COPD in elderly patients as compared to an expert panel diagnosis. Incorporating FEV1 and RV/TLC into the GOLD-COPD or LLN-based definition brings both definitions closer to expert panel diagnosis of COPD, and to daily clinical practice.Chronic obstructive pulmonary disease (COPD) is among the leading causes of disability and death in developed countries. The prevalence of COPD is still on the rise, and costs for the health system are substantial [1,2]. Airflow limitation that is not fully reversible after bronchodilator application is a key feature of COPD, and spirometry is the routine diagnostic procedure of choice recommended to diagnose COPD [3,4]. However, the degree of obstruction that establishes the diagnosis of COPD is still under debate [5]
%K COPD diagnosis
%K lower limit of normal
%K GOLD
%K validation
%U http://respiratory-research.com/content/13/1/13